Itau Unibanco Holding S.A. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Itau Unibanco Holding S.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$32.77 - $53.49 $2,883 - $4,707	88 New	88 $3,000
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $13,728 - $19,370	-336 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$39.79 - $67.01 $44,286 - $74,582	-1,113 Reduced 76.81%	336 $15,000
Q4 2018 Feb 13, 2019	BUY	$29.75 - $42.9 $13,714 - $19,776	461 Added 46.66%	1,449 $51,000
Q3 2018 Nov 13, 2018	SELL	$32.79 - $43.0 $2,098 - $2,752	-64 Reduced 6.08%	988 $37,000
Q2 2018 Aug 13, 2018	SELL	$23.62 - $42.29 $24,588 - $44,023	-1,041 Reduced 49.74%	1,052 $41,000
Q1 2018 May 14, 2018	BUY	$22.49 - $34.56 $28,292 - $43,476	1,258 Added 150.66%	2,093 $54,000
Q4 2017 Feb 09, 2018	BUY	$20.44 - $35.56 $6,540 - $11,379	320 Added 62.14%	835 $22,000
Q3 2017 Nov 14, 2017	BUY	$23.54 - $38.21 $12,123 - $19,678	515	515 $61,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.6B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.